StockData
NRX Pharmaceuticals, Inc. logo

NRX Pharmaceuticals, Inc. (NRXP) stock

NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.45+0.30 (+13.95%)

Close on Nov 17, 2026Market cap $106.08MP/E –Yield –

NRX Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

NRX Pharmaceuticals's gross margin for the twelve months ending Jun 30, 2026 was 46.6%. For fiscal 2025 it was 58.8%.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202558.8%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202638.7%–
Q1 FY2026Mar 31, 202640.9%–
Q4 FY2025Dec 31, 202558.5%–
Q3 FY2025Sep 30, 202559.9%–

More NRX Pharmaceuticals figures

See a number that looks wrong?